Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression

INTRODUCTION: Pre-existing conditions relevant for adverse events (AE) and the potential for drug–drug interactions (DDIs) may limit safe pharmacotherapeutic augmentation options for patients with major depressive disorder (MDD). This concern may be heightened among patients with treatment-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhdanava, Maryia, Karkare, Swapna, Pilon, Dominic, Joshi, Kruti, Rossi, Carmine, Morrison, Laura, Sheehan, John, Lefebvre, Patrick, Lopena, Oliver, Citrome, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408057/
https://www.ncbi.nlm.nih.gov/pubmed/34368919
http://dx.doi.org/10.1007/s12325-021-01862-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408057/
https://www.ncbi.nlm.nih.gov/pubmed/34368919
http://dx.doi.org/10.1007/s12325-021-01862-z

Ejemplares similares